S&P 500

5.473,23

0,77%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Aravive Inc (ARAV)
Aravive Inc (ARAV) Notícias

ARAV

Aravive (ARAV)

Aravive Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ARAV

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/02/2024	09:00	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:ARAV	Aravive Inc
02/02/2024	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ARAV	Aravive Inc
29/01/2024	18:17	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:ARAV	Aravive Inc
29/01/2024	18:10	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ARAV	Aravive Inc
29/01/2024	18:06	Edgar (US Regulatory)	Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:ARAV	Aravive Inc
17/01/2024	18:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARAV	Aravive Inc
17/01/2024	18:09	GlobeNewswire Inc.	Aravive, Inc. to Delist from The Nasdaq Stock Market	NASDAQ:ARAV	Aravive Inc
09/11/2023	18:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARAV	Aravive Inc
22/09/2023	18:04	Edgar (US Regulatory)	Form DEFR14A - Revised definitive proxy soliciting materials	NASDAQ:ARAV	Aravive Inc
05/09/2023	17:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ARAV	Aravive Inc
25/08/2023	08:30	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ARAV	Aravive Inc
24/08/2023	18:18	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ARAV	Aravive Inc
14/08/2023	17:06	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:ARAV	Aravive Inc
20/06/2023	17:12	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ARAV	Aravive Inc
05/06/2023	17:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARAV	Aravive Inc
10/05/2023	17:08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARAV	Aravive Inc
01/05/2023	13:50	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:ARAV	Aravive Inc
19/04/2023	17:32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ARAV	Aravive Inc
11/04/2023	17:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARAV	Aravive Inc
11/04/2023	17:07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARAV	Aravive Inc
15/03/2023	08:07	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ARAV	Aravive Inc
14/02/2023	18:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARAV	Aravive Inc
28/12/2022	18:01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ARAV	Aravive Inc
29/11/2022	10:04	Dow Jones News	Aravive Shares Rise Premarket on FDA Fast-Track Designation for Batiraxcept	NASDAQ:ARAV	Aravive Inc
17/11/2022	18:06	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ARAV	Aravive Inc
10/11/2022	12:15	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for Aravive (ARAV)	NASDAQ:ARAV	Aravive Inc
28/10/2022	17:12	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:ARAV	Aravive Inc
10/10/2022	17:05	GlobeNewswire Inc.	Aravive Receives Third Development Milestone from 3D Medicines	NASDAQ:ARAV	Aravive Inc
26/09/2022	09:00	GlobeNewswire Inc.	Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference	NASDAQ:ARAV	Aravive Inc
06/09/2022	17:05	GlobeNewswire Inc.	Aravive to Participate in H.C. Wainwright 24th Annual Global Investment Conference	NASDAQ:ARAV	Aravive Inc